BridgeMD
New treatment option for PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
Official title Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycystic Ovary Syndrome
ClinicalTrials.gov ID: NCT07182526
What this study is testing
What is Quercetin?
Quercetin is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for pcos (polycystic ovary syndrome) of bilateral ovaries.
Also referred to as Quercetin 500 mg capsule, NOW pharmacetics.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study will investigate whether the addition of Quercetin or Alpha-Lipoic Acid (ALA) to standard metformin therapy can improve symptoms, hormone levels, metabolic health, and quality of life in women with polycystic ovary syndrome (PCOS). Over 3 months, participants will be randomly assigned to one of three groups: metformin alone, metformin plus Quercetin, or metformin plus ALA.
- Phase 2: a mid-size study of how well it works
- Time commitment: about 3 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Newly diagnosed patients should be at reproductive aged from 18-40 years.
- Patients diagnosed with presence of micro polycystic ovaries at ultrasound.
- Oligomenorrhea with inter-menstrual intervals longer than 35 days.
- Clinical or biochemical signs of hyperandrogenism (acne, hirsutism).
- Normal PRL levels.
You likely can't join if
- Presence of enzymatic adrenal deficiency and/or other endocrine disease, including diabetes.
- Other comorbidities (such as hypertension, cardiovascular disease, or hormonal dysfunction).
- Women who used oral contraceptives, hormonal therapy, or anti-lipidemic drugs.
- Pregnant women.
The study team makes the final eligibility decision.
Where it's taking place
- Baghdad, Karkh, Iraq
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 3 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Baghdad, Karkh, Iraq. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.